Foxo Technologies Inc
FOXO0.150USD
-0.006-3.71%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
51.49KCap. mercado
PérdidaP/E TTM
Más Datos de Foxo Technologies Inc Compañía
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Información de la empresa
Símbolo de cotizaciónFOXO
Nombre de la empresaFoxo Technologies Inc
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoMr. Seamus Lagan
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 11
Dirección477 South Rosemary Avenue
CiudadWEST PALM BEACH
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal33401
Teléfono16128000059
Sitio Webhttp://delwinds.com/
Símbolo de cotizaciónFOXO
Fecha de salida a bolsaDec 11, 2020
Director ejecutivoMr. Seamus Lagan
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
167.00
--
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
167.00
--
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Rennova Health, Inc.
0.96%
Clearthink Capital Partners LLC
0.56%
Kr8 ai Inc
0.22%
UBS Financial Services, Inc.
0.14%
Geode Capital Management, L.L.C.
0.14%
Other
97.97%
Accionistas
Accionistas
Proporción
Rennova Health, Inc.
0.96%
Clearthink Capital Partners LLC
0.56%
Kr8 ai Inc
0.22%
UBS Financial Services, Inc.
0.14%
Geode Capital Management, L.L.C.
0.14%
Other
97.97%
Tipos de accionistas
Accionistas
Proporción
Corporation
1.75%
Investment Advisor
0.21%
Investment Advisor/Hedge Fund
0.17%
Research Firm
0.05%
Hedge Fund
0.03%
Other
97.80%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
42
117.55K
2.20%
-40.11K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
2023Q1
129
1.99M
69.67%
-1.77M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Rennova Health, Inc.
102.36K
0.96%
-1.00
-0.00%
May 21, 2025
Clearthink Capital Partners LLC
60.00K
0.56%
+60.00K
--
Dec 01, 2023
Kr8 ai Inc
23.70K
0.22%
-1.00
-0.00%
May 21, 2025
UBS Financial Services, Inc.
15.02K
0.14%
+1.03K
+7.33%
Mar 31, 2025
Geode Capital Management, L.L.C.
14.40K
0.14%
+10.16K
+239.24%
Mar 31, 2025
SBI Securities Co., Ltd.
5.10K
0.05%
+1.17K
+29.67%
Mar 31, 2025
Corbin Capital Partners, L.P.
2.75K
0.03%
--
--
Dec 31, 2024
Capital Investment Advisory Services, LLC
2.50K
0.02%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.42K
0.02%
--
--
Mar 31, 2025
State Street Global Advisors (US)
2.00K
0.02%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Fecha
Tipo
Relación
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
